Product Details
Coageight 500 IU Injection In Pakistan
Coageight 500 IU Injection is a recombinant coagulation Factor VIII medicine used for the treatment and prevention of bleeding episodes in people with Hemophilia A, a condition caused by insufficient Factor VIII. It works by replacing the deficient clotting factor and helping the blood form stable clots. Coageight is manufactured by AryoGen Pharmed and is supplied as a lyophilized powder for preparation before intravenous administration.
Benefits
- Factor VIII Replacement: Replaces deficient Factor VIII needed for normal blood clotting.
- Bleeding Control: Used to help control bleeding episodes associated with Hemophilia A.
- Bleeding Prevention: May be prescribed for routine prophylaxis to reduce recurrent bleeding.
- Surgical Support: Can be used for bleeding management around appropriate surgical procedures.
- Recombinant Formulation: Provides recombinant coagulation Factor VIII rather than relying on directly donated blood plasma.
Specifications
| Specification | Details |
|---|---|
| Product Name | Coageight 500 IU Injection |
| Active Ingredient | Recombinant Coagulation Factor VIII |
| Strength | 500 IU |
| Dosage Form | Lyophilized powder for injection |
| Route | Intravenous (IV) |
| Main Use | Treatment and prevention of bleeding in Hemophilia A |
| Manufacturer | AryoGen Pharmed |
| Pack Size | 1 vial |
| Prescription Status | Prescription medicine |
How To Use
Coageight 500 IU should be administered intravenously according to the prescription of a hematologist or other qualified healthcare professional. The required dose is individualized according to factors such as body weight, severity and location of bleeding, Factor VIII levels, and clinical response.
- Reconstitute the powder only according to the manufacturer's instructions.
- Administer by the intravenous route.
- Do not self-inject unless specifically trained and instructed by your healthcare team.
- The dose and frequency should be determined by the treating physician.
- Patients may require monitoring for Factor VIII inhibitor development, particularly when treatment becomes less effective.
Why Choose Coageight 500 IU Injection?
- Contains recombinant Factor VIII for Hemophilia A management.
- Designed for treatment and prevention of bleeding episodes.
- Available in a convenient 500 IU vial strength.
- Can be incorporated into individualized prophylactic or on-demand treatment plans.
- Manufactured by AryoGen Pharmed.
